gazette | Ministry-of-Chemicals-and-Fertilizers | Department-of-Pharmaceuticals

- Department of Pharmaceuticals

Whereas the Ministry of Chemicals and Fertilizers vide S O 1394 E dated 30th May 2013 in exercise of the powers conferred by Section 3 and 5 of Essential Commodities Act

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-09-26

- Department of Pharmaceuticals

Government of India in the Ministry of Chemicals and Fertilizers the National Pharmaceutical Pricing Authority hereinafter referred as NPPA hereby fixes

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-09-26

- Department of Pharmaceuticals

In continuation to the Notifications issued by National Pharmaceutical Pricing Authority Department of Pharmaceuticals

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-09-16

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

Not Applicable--Part II-Section 3-Sub-Section (ii)-2020

2020-08-27

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of The Drugs Prices Control Order 2013 read

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-08-20

- Department of Pharmaceuticals

In continuation to the Notifications issued by National Pharmaceutical Pricing Authority Department

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-08-14

- Department of Pharmaceuticals

In the National Pharmaceutical Pricing Authoritys notification SO 2293E dated 10th July 2020 relating to fixation of retail price

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-07-23

- Department of Pharmaceuticals

1 Drugs play a major role in healthcare delivery in the country Continuous supply of drugs is necessary to ensure delivery of affordable healthcare to the citizens

Not Applicable--Part I-Section 1-2020

2020-07-21

- Department of Pharmaceuticals

1 1 The medical device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies

Not Applicable--Part I-Section 1-2020

2020-07-21

- Department of Pharmaceuticals

Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order s of the Government of India in the Ministry of Chemicals and Fertilizers National Pharmaceutical Pricing Authority

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-07-10

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order 2013

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-06-30

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-06-09

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-05-29

- Department of Pharmaceuticals

In exercise of the powers conferred by sections 3 and 5 of the Essential Commodities Act

Not Applicable--Part II-Section 3-Sub-Section (ii)-2020

2020-04-07

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-04-04

- Department of Pharmaceuticals

In pursuance of Notification No S O 648 E dated 11th February 2020 issued by Ministry of Health and Family Welfare

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-04-01

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraph 4 6 10 11 14 16 17 and 18 of the Drugs

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-03-25

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-03-05

- Department of Pharmaceuticals

In continuation to the notifications issued by National Pharmaceutical Pricing Authority Department of Pharmaceuticals Ministry of Chemical and Fertilizers

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-02-29

- Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

National Pharmaceuticals Pricing Authority--Part II-Section 3-Sub-Section (ii)-2020

2020-02-07

Data Coverage

Doc Type

Ministry

Department

Year

Year

Whereas the Ministry of Chemicals and Fertilizers vide S O 1394 E dated 30th May 2013 in exercise of the powers conferred by Section 3 and 5 of Essential Commodities Act

Government of India in the Ministry of Chemicals and Fertilizers the National Pharmaceutical Pricing Authority hereinafter referred as NPPA hereby fixes

In continuation to the Notifications issued by National Pharmaceutical Pricing Authority Department of Pharmaceuticals

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

In exercise of the powers conferred by paragraphs 5 11 and 15 of The Drugs Prices Control Order 2013 read

In continuation to the Notifications issued by National Pharmaceutical Pricing Authority Department

In the National Pharmaceutical Pricing Authoritys notification SO 2293E dated 10th July 2020 relating to fixation of retail price

1 Drugs play a major role in healthcare delivery in the country Continuous supply of drugs is necessary to ensure delivery of affordable healthcare to the citizens

1 1 The medical device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies

Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the Order s of the Government of India in the Ministry of Chemicals and Fertilizers National Pharmaceutical Pricing Authority

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order 2013

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control

In exercise of the powers conferred by sections 3 and 5 of the Essential Commodities Act

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control

In pursuance of Notification No S O 648 E dated 11th February 2020 issued by Ministry of Health and Family Welfare

In exercise of the powers conferred by paragraph 4 6 10 11 14 16 17 and 18 of the Drugs

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order

In continuation to the notifications issued by National Pharmaceutical Pricing Authority Department of Pharmaceuticals Ministry of Chemical and Fertilizers

In exercise of the powers conferred by paragraphs 5 11 and 15 of the Drugs Prices Control Order